Tevogen (TVGN) Assets (2021 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Assets came in at $4.9 million in Q1 2026, up 20.81% YoY from $4.1 million in Q1 2025, and up 12.27% on a QoQ basis from $4.4 million in Q4 2025.
Tevogen (TVGN) Assets (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 6 years of Assets data on file, last reported at $4.9 million in Q1 2026.
- Quarterly Assets rose 20.81% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 20.81% YoY) and the FY2025 annual result came in at $4.4 million, up 26.61% from the prior year.
- Assets advanced to $4.9 million in Q1 2026, from $4.4 million in the prior quarter.
- In the past five years, Assets ranged from a high of $357.1 million in Q4 2022 to a low of $3.3 million in Q2 2024.
- A 5-year average of $90.5 million and a median of $4.9 million in 2026 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets slumped 98.46% — and 2025, when it rose 28.97%.
- Tracing TVGN's Assets over 5 years: stood at $357.1 million in 2022, then tumbled by 98.46% to $5.5 million in 2023, then plunged by 37.12% to $3.5 million in 2024, then advanced by 26.61% to $4.4 million in 2025, then climbed by 12.27% to $4.9 million in 2026.
- The last three Assets figures came in at $4.9 million (Q1 2026), $4.4 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 19.82 Bn |
| 10 | Tevogen | 26.21 Mn | 26.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 5.51 Mn |
| Sep 30, 2023 | 26.41 Mn |
| Jun 30, 2023 | 26.38 Mn |
| Mar 31, 2023 | 25.47 Mn |
| Dec 31, 2022 | 357.14 Mn |
| Sep 30, 2022 | 354.54 Mn |
| Jun 30, 2022 | 352.98 Mn |
| Mar 31, 2022 | 352.83 Mn |
| Dec 31, 2021 | 352.85 Mn |